CJMB vs CRL · rev $5.7M vs rev $2.00B
Callan JMB Inc. Common Stock (CJMB) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Callan JMB Inc. Common Stock (CJMB) is a integrated freight & logistics company listed on NASDAQ.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported CJMB revenue for 2025-12-31 was $5.7M. Net income was -$8.0M. Revenue was down 12.8% from 2024-12-31 to 2025-12-31. CJMB currently screens at market cap $4.1M.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
CJMB currently screens at market cap $4.1M. CRL currently screens at market cap $7.78B.
Not investment advice. Open the CJMB and CRL stock pages for the full models.
Not investment advice.